Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma — All StAGEs: A consensus‐based position paper from the Hodgkin lymphoma subgroup of the UK National Cancer Research Institute. (1st April 2022)

• Record Type: Journal Article
• Authors: Shankar, Ananth; Hall, Georgina W.; McKay, Pam; Gallop‐Evans, Eve; Fielding, Patrick; Collins, Graham P.
• Is Part Of: British journal of haematology. Volume 197:Number 6(2022)
• Page Start: 679
• Page End: 690
• Publication Date: 2022-04-01
• Subjects: all ages -- all stages -- low‐intensity chemotherapy -- radiotherapy -- rituximab -- transformation; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; 616.15
• DOI: 10.1111/bjh.18169
• Languages: English
• ISSNs: 0007-1048

Abstract

Summary: A consensus statement for the management for patients of all ages with all stages of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) — All St AGE s — is proposed by representatives of the UK National Cancer Research Institute (NCRI) Hodgkin lymphoma study group and the Children's Cancer & Leukaemia Group. Based on current practices and published evidence, a consensus has been reached regarding diagnosis, staging and risk‐ik7 stratified management which includes active surveillance, low‐ and standard‐dose immunochemotherapy and radiotherapy.